
Vigroz MV 2mg/500mg/0.2mg Tablet
Marketer
Zylig Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Vigroz MV 2mg/500mg/0.2mg Tablet
Diabetol Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabetol Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, risking complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.
Uses of Vigroz MV 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vigroz MV 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vigroz MV 2mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Vigroz MV 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vigroz MV 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vigroz MV 2mg/500mg/0.2mg tablet whole; do not crush, chew, or divide it. Administer on an empty stomach.
How Vigroz MV 2mg/500mg/0.2mg Tablet works:
Each Vigroz MV tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vigroz MV 2mg/500mg/0.2mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Vigroz MV 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before using this medicine.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Vigroz MV 2mg/500mg/0.2mg tablets is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Vigroz MV 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Vigroz MV 2mg/500mg/0.2mg Tablets is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Vigroz MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Vigroz MV 2mg/500mg/0.2mg Tablet :
Should you forget a dose of Vigroz MV 2mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vigroz MV 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
